Form 4: Oscar Health Director Jeffery Boyd Receives Significant RSU Grant

Oscar Health, Inc. Director Jeffery H. Boyd was granted 14,134 restricted stock units (RSUs) on June 4, 2025, increasing his beneficial ownership to 705,673 shares of Class A Common Stock.

Summary

• Jeffery H. Boyd, a Director of Oscar Health, Inc. (OSCR), acquired 14,134 shares of Class A Common Stock in the form of Restricted Stock Units (RSUs) on June 4, 2025.
• The RSUs were granted at a price of $0.00 per unit, indicating they are part of compensation.
• Following this transaction, Mr. Boyd's direct beneficial ownership of Class A Common Stock increased to 705,673 shares.
• Each RSU represents a contingent right to receive one share of Oscar Health, Inc. Class A common stock.
• The RSUs are subject to vesting, which occurs on the earlier of the one-year anniversary of the grant date (June 4, 2026) or the date of the next annual meeting of stockholders following the grant date, contingent on continued service.
• Vested RSUs will be settled in shares upon the earliest of six months after separation from service, death, disability, or within five days following a change in control of the Issuer.

Sentiment

Score: 7

Explanation: The grant of RSUs to a director is a positive signal of continued alignment between management/board and shareholder interests, and a standard component of compensation. It does not indicate any negative operational or financial news.

Positives

• The grant of 14,134 Restricted Stock Units (RSUs) to Director Jeffery H. Boyd aligns his interests with long-term shareholder value, as the value of these units is tied to the company's stock performance.
• The increase in beneficial ownership to 705,673 shares demonstrates continued commitment and confidence from a key board member.

Negatives

• No specific negatives are identified in this Form 4 filing, which primarily reports an equity grant.

Risks

• The vesting of the RSUs is subject to continued service, meaning the director must remain with the company for the units to fully vest.
• The ultimate value of the RSUs is dependent on the future market price of Oscar Health, Inc. Class A common stock, exposing the director to market risk.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future financial performance or strategic outlook, focusing solely on an insider's equity transaction.

Industry Context

This filing is a routine disclosure of an insider equity transaction and does not provide information related to broader industry trends or competitive landscape within the health insurance technology sector. It reflects standard compensation practices for board members.

Corporate Governance

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's interests with shareholders, as the value of the grant is tied to the company's stock performance. It also represents a potential future dilution if new shares are issued upon vesting, though this is standard for equity compensation.

Next Steps

• The RSUs will vest on the earlier of the one-year anniversary of the grant date (June 4, 2026) or the date of the next annual meeting of stockholders following the grant date, subject to continued service.
• Vested RSUs will be settled in shares upon the earliest of six months after separation from service, death, disability, or within five days following a change in control of the Issuer.

Key Dates

Recommendation

Keywords

Oscar Health, OSCR, Jeffery H. Boyd, Director, Restricted Stock Units, RSU, Insider Transaction, SEC Form 4, Equity Grant, Beneficial Ownership, Corporate Governance